Introduction
Vasculitides are heterogeneous diseases characterized by changes in vessel wall as a consequence of an inflammatory process. Clinical characteristics depend on the size, type, and location of the vessels involved. Primary vasculitides are regarded to be more common in adults than children [1] [2] [3] . The estimated incidence for pediatric vasculitides is around 50 cases per 100,000 children annually [4] . Although the overall incidence is
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Because of the heterogeneous nature of vasculitis and limited knowledge about their causes, it is difficult to identify proper subgroups. There are different categorization attempts and criteria sets for vasculitis. A nomenclature system forms a framework for developing classification/diagnostic criteria by providing names and definitions [6] . Classification criteria are mainly for defining more homogeneous patient groups for research purposes [7] while diagnostic criteria are applied to the individual patient to diagnose the disease by ruling out other mimicking conditions [8] . In fact, we could say that unlike classification criteria, diagnostic criteria should be both 100% sensitive and specific [9] . In the case of primary vasculitides, the diagnosis does not rely on a single pathognomonic test thus the term "classification criteria" seems more appropriate than "diagnostic criteria" [10] .
Here, we review the current nomenclature, classification system, and classification criteria of vasculitides in childhood.
Progress in vasculitis nomenclature and classification
In 1994, an international conference was held in Chapel Hill (CHCC, Chapel Hill Consensus Conference) to develop a nomenclature system for vasculitides and they distinguished vasculitis by the size of the vessels predominantly affected [11] . The International CHCC convened again in 2012 and they modified the nomenclature system by adding some new categories such as variable vessel vasculitis (VVV) and singleorgan vasculitis (Table 1) [12] .
The American College of Rheumatology (ACR) proposed a series of classification criteria for vasculitis in adults in 1990 [13, 14] . However, the ACR criteria set did not refer to anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV), excluded microscopic polyangiitis (MPA) as a disease category, omitted KD, and has never been validated in children [13] [14] [15] [16] [17] [18] . With this background, preliminary classification criteria were proposed in 2005 for some of the most common vasculitides in childhood such as HSP (now [19] [20] [21] . Both ACR and Ankara 2008 criteria were derived from a large database compared to cases with other vasculitis as controls. This information implies that these criteria sets should be used to discriminate the subclass of disease in cases with a prior knowledge of vasculitis [10] . The main characteristics of the ACR [15] [16] [17] [18] and Ankara 2008 criteria [20] are summarized in Table 2 .
In 2010, EULAR established an expert panel to identify deficiencies in the ACR criteria and CHCC 1994 nomenclature [22] . They have mentioned 17 points for development of revised classification and diagnostic criteria [22] . These points were mainly about the definitions, nosology, biopsy, laboratory testing (e.g., use of ANCA), diagnostic radiology, and the research agenda. Most of these points had already been incorporated in the Ankara 2008 criteria [20] and CHCC 2012 met the need for a classification tree [12] .
Currently, there are no diagnostic criteria available for the primary systemic vasculitis and classification criteria are used for diagnosis in clinical practice, albeit with a low sensitivity [23] . To develop and validate diagnostic criteria and to improve classification criteria, the "diagnostic and classification criteria for vasculitides (DCVAS)" study is currently underway which promises further progress in the area of vasculitis criteria [24] .
CHCC 2012: categorization of vasculitis With the improved understanding of the etiopathogenesis, the categorization, names, and definitions for vasculitis were updated in CHCC 2012 (Table 1 ) [12] . Most of the eponyms were replaced by the terms that describe the pathogenesis of the disease. In addition, new vasculitis categories were included in order to separate VVV, single-organ vasculitis, vasculitis associated with systemic disease, and vasculitis associated with probable etiology. The categorization mainly depends on the size of the predominantly involved vessel; however, in CHCC 2012, they also took into account the pathogenesis especially while subcategorizing small-vessel vasculitis (SVV) [12] .
There are some shortcomings of CHCC 2012. First of all, the categorization still depends on mainly on vessel size; however, the vessel involvement of different vasculitis categories may overlap. Besides, it may be difficult to define the size of the involved vessel through pathologic examination in some cases [10] . There are a group of patients who are classified as having AAV with no detectable ANCA. It is challenging to fit these patients into any category in CHCC 2012 [10] . In addition, recently, new diseases have been defined in which monogenic defects result in vasculopathy such as deficiency of adenosine deaminase 2 (DADA2) [25, 26] and stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy (SAVI) [27] . These diseases may be classified under the category of "vasculitis associated with a probable cause" but do not perfectly fit. There could be a separate subcategory called "monogenic vasculopathies".
Large-vessel vasculitis (LVV)
Large-vessel vasculitis (LVV) mainly affects the aorta and its large branches and the major subcategories of LVV are TA and giant cell arteritis (GCA) [12] . TA is defined as granulomatous aorta arteritis usually occurring before age of 50 years [12] and it is the only LVV referred to in current pediatric classifications [20] .
GCA is defined as granulomatous aorta arteritis predominantly involving the carotid and vertebral arteries occurring after age 50 years and often associated with polymyalgia rheumatica [12] . GCA almost never occurs during childhood [5] . The major discriminating factor between TA and GCA appears to be the age of patient at LVV onset in CHCC 2012 [12] .
In Ankara 2008 criteria (Table 2) , "angiographic anomalies" criterion was modified to include imaging modalities such as computerized tomography (CT) and magnetic resonance imaging and was made a mandatory criterion [20] . Hypertension which may be the only symptom in children and elevation in acute phase reactants which may warn the physician before the symptoms settle were also included in the criteria. With all these modifications, the criteria had a sensitivity of 100% and specificity of 99% in children [20] . 
Medium-vessel vasculitis (MVV)
Medium-vessel vasculitis (MVV) predominantly targets medium-sized arteries which are defined as the main visceral arteries and their branches; however, it can affect any size artery [12] . It has two major subcategories as PAN and KD.
PAN is defined as the necrotizing vasculitis of medium/ small-sized arteries without glomerulonephritis or vasculitis in arterioles, venules, and capilleries and it is not associated with ANCA [12] . Thus, kidney involvement is due to the vasculitis of lobar and arcuate arteries, not glomerular capillaries. The main revision in CHCC 2012 was the addition of negative ANCA to the definition [12] . PAN is the third most common vasculitis after IgAV/HSP and KD in children [28, 29] . Due to vaccination protocols, hepatitis B serology positivity is unusual in pediatric PAN [28] . Furthermore, if PAN-like vasculitis is demonstrated to be related to hepatitis B infection, it should be classified under the category of "vasculitis associated with probable etiology" [12] . Because of this, this criterion (hepatitis B serology) was removed while forming the Ankara 2008 criteria for pediatric PAN [20] . After designating the typical histopathology or angiographic abnormalities as a mandatory criterion and with the removal of the criteria for the signs and symptoms of vasculitis in specific organ systems and testicular pain/tenderness; pediatric PAN classification criteria took its final form (Table 2 ) [20] . It had a sensitivity of 89.6% and specificity of 99.6% in children [20] .
KD is defined as a mucocutaneous lymph node syndrome with MVV often involving the coronary arteries [12] . It may also involve other medium-sized ateries, but only rarely. KD is predominantly a childhood systemic vasculitis [30] . For the diagnosis of KD, the criteria set formed by the American Heart Association was used [31] . A child is diagnosed as having KD if she/he has fever (for five or more days) plus four of the following 5 criteria: conjunctivitis (bilateral, bulbar, non-suppurative), lymphadenopathy (cervical, often >1.5 cm), rash (polymorphous, no vesicles or crusts), changes in lips and oral mucosa (red cracked lips; 'strawberry' tongue; or diffuse erythema of oropharynx), and changes in extremities (erythema and edema of palms/soles; peeling of skin from fingertips) [31] .
According to the Ankara 2008 criteria, a patient is classified as having KD if she/he has fever persisting for at least five days (mandatory criterion) plus four of the following five criteria: changes in the peripheral extremities and perianal area, polymorphous exanthema, bilateral conjunctival injection, changes of lips and oral cavity and/or injection of oral and pharyngeal mucosa, and cervical lymphadenopathy [20] .
When coronary artery involvement is demonstrated by echocardiography/angiography, children with fewer than four criteria can be diagnosed with KD [31] . In addition, we should keep in mind that infants may have fewer classical signs of KD and patients may present with atypical features such as arthritis, aseptic meningitis, pneumonitis, uveitis, gastroenteritis, meatitis, and otitis [32, 33] .
Small-vessel vasculitis (SVV)
In CHCC 2012, SVV was subclassified into two major divisions depending on the pathogenesis: AAV and immune complex SVV [12] .
After the discovery of ANCA in 1982 [34] , in vitro experiments and animal models documented that ANCA could activate neutrophils and monocytes to mediate vascular inflammation [35] [36] [37] . In CHCC 2012, AAV was defined as necrotizing vasculitis with few or no immune deposits, predominantly affecting small vessels associated with myeloperoxidase (MPO)-or proteinase 3 (PR3)-ANCA [12] . In addition, a prefix should be added to indicate ANCA reactivity [12] . AAV has three subcategories as MPA, GPA/WG, and eosinophilic granulomatosis with polyangiitis/Churg-Strauss syndrome (EGPA/CSS). MPA was not classified as a separate entity prior to CHCC 2012 [12] .
AAV are rare in childhood with an incidence of 2.4 per 1,000,000 children annually and GPA/WG is the most frequently diagnosed one [2] .
MPA is defined as necrotizing vasculitis of small/medium-sized vessels and it is frequently associated with pauciimmune glomerulonephritis and ANCA [12] . On the other hand, GPA/WG is commonly associated with granulomatous inflammation of the respiratory tract besides small/ medium-vessel vasculitis, pauci-immune glomerulonephritis, and ANCA association [12] . Currently clinical methods have demonstrated that at least 80-90% of MPA (mostly MPO-ANCA) and GPA/WG (mostly PR3-ANCA) patients have ANCA [38] . A recent genome-wide association study has provided evidence for subclassification of this disease group (MPA and GPA/WG) by ANCA specificity (PR3 or MPO) than clinical phenotype [39] .
Certain modifications of the ACR criteria were made while forming pediatric classification criteria for GPA/WG. In Ankara 2008 criteria (Table 2) , ANCA positivity was added as a criterion [20] . Since subglottic stenosis has been reported to be more common in pediatric patients [40, 41] ; the presence of subglottic, tracheal, or endobronchial stenosis was also added to the group of criteria [20] . In addition, as a result of progresses in radiology techniques, chest CT was added to the definitions based on radiologic imaging [20] . In its final form, this criteria set had a sensitivity of 93.3% and specificity of 89.2% [20] .
EGPA/CSS is defined as a necrotizing small/medium vessel vasculitis often involving the respiratory tract together with eosinophil-rich granulomatous inflammation [12] . Approximately 40% of EGPA/CSS patients have ANCA [38] . EGPA/CSS is usually characterized by late-onset asthma and frequent non-infectious sinusitis; the rhinitis and sinusitis of EGPA/CSS is often described as "allergic" [42] [43] [44] .
Immune complex SVV is characterized by moderate to marked deposits of Ig and/or complement components predominantly in the walls of small vessels [12] . IgAV/HSP is the most common form of pediatric vasculitis while other immune complex SVV are quite rare in childhood [45, 46] . IgAV/HSP is characterized by arthritis and frequent skin and gastrointestinal vasculitis with IgA deposits and possible IgA nephropathy [12] . Since an abnormal glycosylation of IgA1 hinge region lead to disease process, the descriptive term "IgA vasculitis" replaced the eponym "Henoch-Schönlein" [12] .
During the revision of classification criteria in Ankara 2008 conference, palpable purpura was made a mandatory criterion (Table 2 ) [20] . The IgA depositis are defined as "predominant" to differentiate IgAV/HSP from other diseases with IgA deposits [20, 47] . Joint involvement was more common in children than adults with IgAV/HSP [20] and renal involvement is the main cause for late morbidity and mortality occurring approximately 40% of children with IgAV/HSP within six weeks of presentation [48] . Thus, arthritis and renal involvement were both included in the new criteria set. Age criterion was deleted. The sensitivity and specificity of Ankara 2008 criteria for IgAV/HSP was found as 100% and 87%, respectively [20] . Recently, Hocevar et al have compared the performance of the Ankara 2008 criteria and the ACR criteria for IgAV/HSP for the first time in adult patients with vasculitis [49] . The Ankara 2008 criteria had a higher sensitivity (99.2% vs 86.8%) and specificity (86% vs 81%) than the ACR criteria.
Variable vessel vasculitis (VVV)
Behçet' s disease (BD) and Cogan' s syndrome were included in this category and VVV can affect the vessels of any size and type [12] .
Cogan' s syndrome is a very rare multisystemic inflammatory disease and it is characterized by rapid onset of non-vasculitic ocular inflammatory lesions and inner ear symptoms such as deafness and vertigo [50] . Approximately 10% of these patients develop vasculitis mainly in the form of LVV and systemic symptoms occur in 50% [50, 51] .
BD is characterized by recurrent oral and/or genital aphthous ulcers accompanied by cutaneous, ocular, articular, gastrointestinal, and central nervous system inflammatory lesions [12] . Most BD cases are clustered along the historic Silk Road from Japan to Mediterranean countries [52] with the highest prevalence being reported in Iran and Turkey [53, 54] . It is estimated that 1-2% of BD patients are children [55] .
There are more than 15 sets of diagnostic/classification criteria for BD [56] . According to the International Study Group (ISG) criteria set which was presented in 1990 and 1992 [57, 58] ; diagnosing BD requires the presence of oral aphthosis (mandatory) plus two of the following four features: genital aphthosis, skin manifestations (pseudofolliculitis, erythema nodosum), ophthalmologic manifestations, and positive pathergy test. However, many BD patients were not classified as having BD according to the ISG criteria since it had low sensitivity. Thus, a new criteria set called the International Criteria for BD (ICBD) was created in 2006 [59, 60] and revised in 2014 [61] . In the revised ICBD, the patient is classified as having BD if she/he gets four or more points [61] . The patient gets two points for each of oral aphthosis, genital aphthosis, ophthalmologic involvement; and one point for each of skin, neurologic, and vascular manifestations and positive pathergy test. ICBD was found to be more sensitive than the ISG criteria although at the expense of a small decrease in specificity [57] . Recently, Nanthapisal et al compared the performance of ISG criteria and ICBD in pediatric BD cases and showed that ICBD was more sensitive than the ISG criteria (14.7% vs 80.4%) [62] . The specificity could not be measured because of the lack of a control group.
These criteria sets were mainly developed from studies on adult patients and none has been validated in children. However, BD characteristics differ between children and adults. Besides, the disease is not complete before 16 years of age in more than 80% of patients [63] . With this background, most recently, the pediatric BD (PEDBD) group has determined new classification criteria for children with BD [64] . Pathergy test was excluded and all symptom categories have equal weight in this criteria set. According to the PEDBD criteria, a patient is classified as having BD if she/he had ≥3 of the following characteristics: oral aphthosis (≥3 attacks/ year), genital aphthosis (typical with scars), skin involvement (necrotic folliculitis, acneiform lesions, erythema nodosum), neurologic involvement (except isolated headaches), ocular manifestations (anterior uveitis, posterior uveitis, retinal vasculitis), and vascular signs (venous thrombosis, arterial thrombosis, arterial aneurysm) [64] .
Single-organ vasculitis Single-organ vasculitis is defined as vasculitis in a single organ with no features indicating a limited form of a systemic vasculitis [12] . Before classifying a patient as having singleorgan vasculitis, the patient should be followed for a certain time period (minimum six months) to rule out progression to systemic vasculitis [65] . The single-organ vasculitis may also be primary or secondary in etiology and subcategorization in that manner may help with the guidance of proper treatment.
Other vasculitis
Other categories are vasculitis associated with systemic disease and vasculitis associated with probable cause [12] . These are mainly secondary vasculitis and the causes include systemic diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus), cancer, drug exposure, and infection (e.g., hepatitis viruses) [10] . With the revision in the classification tree in CHCC 2012 [12] , hepatitis B-associated PAN-like vasculitis is no longer classified in the subcategory of PAN, but it is classified in "vasculitis associated with probable cause" category [12] . This distinction is based mainly on etiopathogenesis and it is highly relevant since these cases can benefit from a causebased management [66] .
An autosomal recessive disorder called DADA2 has recently been described and it causes a vasculopathy with autoinflammatory features associated with mutations in the CECR1 gene [25, 26] . The phenotype of DADA2 varies from only cutaneous lesions to full-blown systemic disease which may overlap with the spectrum of PAN [25, 26, 67] . Another recently described monogenic disease is SAVI caused by mutations in the TMEM173 gene and it causes a severe cutaneous vasculopathy leading to extensive tissue loss [27] . These monogenic vasculopathies may be classified under the category of vasculitis associated with probable cause. However, a separate subcategory like "monogenic vasculopathies" could be more appropriate.
Conclusion
There have been important advances in diagnostic technology and improvement in our understanding of etiopathogenesis in the area of vasculitis. Based on this, vasculitis nomenclature and classification system also evolved. CHCC 2012 nomenclature and classification system which depends both on the involved vessel size and etiopathogenesis, remains the most practical way to categorize vasculitis. Further multicenter prospective studies will help to incorporate the classification systems more into the clinical practice. Diagnostic criteria are also very important in clinics for patients with vasculitis and this will hopefully be achieved by DCVAS study [24] .
